Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 2Phase NA 1Phase 3 1

Status

Recruiting 5Active not recruiting 3

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Dermatologic 3CNS 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Melanoma 3Warts 1Uveal Melanoma 1Tuberous Sclerosis 1Seizures 1Recurrence 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lennox Gastaut Syndrome 1Hyperthermia 1Hemorrhage 1Hematologic Neoplasms 1Glioblastoma 1Epilepsies, Myoclonic 1Brain Neoplasms 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Solutions × 1 year × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT07565350 2026-05-04

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

First Hospital of China Medical University

Phase NA Recruiting
80 enrolled

Hyperthermia, Warts

NCT05952804 2026-04-21

IVIG for Infection Prevention After CAR-T-Cell Therapy

Fred Hutchinson Cancer Center

Phase 2 Recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Nova Scotia Health Authority

Phase 3 Recruiting
102 enrolled
CNS

Brain Neoplasms, Hemorrhage

NCT04752826 2026-02-18

MK-3475-D20

BioInvent International AB

Phase 1/2 Recruiting
176 enrolled
DermatologicGynecologicLymphoid

Melanoma, Ovarian Neoplasms, Lymphoma, T-Cell

NCT07230613 2026-02-11

NEOREM-NEO-1

UNICANCER

Phase 2 Recruiting
50 enrolled
Dermatologic

Melanoma

NCT03233152 2025-11-21

GlitIpNi

Universitair Ziekenhuis Brussel

Phase 1/2 Active not recruiting
110 enrolled
CNS

Glioblastoma, Recurrence

NCT06784648 2025-11-19

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

BioInvent International AB

Phase 1/2 Active not recruiting
35 enrolled
Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡